Skip to main content

Table 3 Predictors of poor functional outcome at 90 days (univariate ordinal regression)

From: Low (0–5) Alberta Stroke Program Early Computed Tomography Score on admission predictive of worse functional outcome after mechanical thrombectomy for anterior circulation large vessel occlusion

Characteristic

OR

95%CI

P value

Age, y

1.062

1.041–1.084

 < 0.001a

Female

1.30

0.818–2.067

0.267

Hypertension

1.136

0.740–1.745

0.559

Diabetes mellitus

2.574

1.545–4.287

 < 0.001a

Hyperlipidemia

0.790

0.498–1.252

0.315

Atrial fibrillation/flutter

1.531

0.987–2.373

0.057

Coronary artery disease

1.577

0.914–2.720

0.101

Current/prior tobacco use

0.715

0.467–1.094

0.122

Current/prior alcohol intake

0.669

0.437–1.025

0.065

TOAST classification

0.885

0.578–1.356

0.575

Large artery atherosclerosis

Cardioembolism

Other determined etiology

 Prestroke

1.484

0.887–2.483

0.133

 Baseline NIHSS score

1.143

1.082–1.208

 < 0.001a

 HMCAS

0.857

0.554–1.326

0.489

 Signs of early infarction

1.634

1.052–2.539

0.029*

 DBP on admission

0.988

0.974–1.002

0.090

 SBP on admission

0.997

0.988–1.005

0.461

 HbA1c

1.486

1.279–1.728

 < 0.001a

 D-dimer

1.144

1.040–1.259

0.006a

 Occlusive location

0.731

0.599–0.892

0.002a

ICA

MCA M1

MCA M2

ICA + MCA

 IV tPA

1.013

0.617–1.665

0.958

 Oneset to puncture, min

0.999

0.999–1.000

0.086

 Device passes

1.539

1.186–1.997

0.001a

 Balloon-guided catheter

0.783

0.474–1.292

0.338

 Angioplasty and stenting

1.807

0.782–4.176

0.166

 Successful reperfusion

0.324

0.189–0.555

 < 0.001a

 Symptomatic ICH

1.782

1.080–2.941

0.024a

 ASPECTS ≤ 5

2.169

1.147–4.100

0.017a

  1. Significant values in bold
  2. aTOAST Trial of Org 10172 in Acute Stroke Treatment, NIHSS National Institutes of Health Stroke Scale, HMCAS hyperdense middle cerebral artery sign; DBP, diastolic blood pressure, SBP systolic blood pressure, HbA1c glycosylated hemoglobin, ICA internal carotid artery, MCA middle cerebral artery, IV tPA intravenous tissue plasminogen activator, ASPECTS Alberta Stroke Program Early CT Score